, Tracking Stock Market Picks
Enter Symbol:
Neurometrix, Inc. (NURO) [hlAlert]

up 0.56 %

Neurometrix, Inc. (NURO) rated Buy with price target $2 by Maxim Group

Posted on: Friday,  Sep 11, 2015  8:25 AM ET by Maxim Group

Maxim Group rated Buy Neurometrix, Inc. (NASDAQ: NURO) on 09/11/2015, when the stock price was $0.89. Since
then, Neurometrix, Inc. has gained 0.56% as of 01/04/2016's recent price of $0.89.
If you would have followed this Maxim Group's recommendation on NURO, you would have gained 0.56% of your investment in 115 days.

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2015 8:25 AM Buy
0.89 2.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy